Product Information
MEMANTINE HCL ER 7 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3449 per EA under NDC 16571085203. Its NADAC has been published 30 times since Jan 28, 2026.
FDA first approved this application on Sep 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the memantine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571085203
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206032FDA Approved
9/28/2016
TE Code
AB
On Market Since
6/1/2025
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL ER 7 MG CAPSULE has been published 30 times since Jan 28, 2026, and over the history we have for it it has declined 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3449 per EA |
|---|---|
| All-time high | $0.3657 (Feb 11, 2026) |
| All-time low | $0.2946 (May 20, 2026) |
| 52-week high | $0.3657 |
| 52-week low | $0.2946 |
| Median price | $0.3206 |
| Average price | $0.3236 |
| Largest weekly change | -11.0% (Feb 18, 2026) |
| Weeks tracked | 30 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the memantine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEMANTINE HCL ER 7 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL ER 7 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.3449 per EA (NDC 16571085203), effective Aug 19, 2026.
How has the price of MEMANTINE HCL ER 7 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL ER 7 MG CAPSULE has declined 5.7%. It has been tracked across 30 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL ER 7 MG CAPSULE?
Since Jan 28, 2026, the NADAC for MEMANTINE HCL ER 7 MG CAPSULE has ranged from a low of $0.2946 (May 20, 2026) to a high of $0.3657 (Feb 11, 2026), with a median of $0.3206 per EA.
Are there cheaper alternatives to MEMANTINE HCL ER 7 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of MEMANTINE HCL ER 7 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEMANTINE HCL ER 7 MG CAPSULE?
MEMANTINE HCL ER 7 MG CAPSULE (NDC 16571085203) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.